Response to Comments: Allergen Immunotherapy (AIT) with Subcutaneous Immunotherapy (SCIT)

This article records and responds to provider comments submitted during the AIT with SCIT LCD (L40046) public comment period and provides administrative dates for the LCD notice and effective periods. It does not itself state clinical coverage criteria or changes; providers should refer to LCD L40046 for specific coverage determinations.

"Article documents comments received during the Allergen Immunotherapy (AIT) with Subcutaneous Immunotherapy (SCIT) LCD comment period from 2025-02-07 to 2025-03-23 and notes the LCD notice period b..."

Sign up to see full coverage criteria, indications, and limitations.